Such severe steatohepatitis in nutrient-overloaded livers was much more likely ameliorated by combined induction of Nrf1 and Nrf2, as therapeutic co-targets for effectively treating the metabolic associated steatohepatitis (MASH). This evidence concerns the gene NFE2L2 and metabolic dysfunction-associated steatohepatitis.